Neuland Laboratories Ltd posts consolidated Q1FY23 PAT of Rs. 9.96 crores

Neuland Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 221.6817 crores during the period ended June 30, 2022 as compared to Rs. 256.5040 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 9.9658 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 21.7807 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 7.77 for the period ended June 30, 2022 as compared to Rs. 16.97 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 221.6817 crs	₹256.5040 crs	-13.58%
Net Profit	₹9.9658 crs	₹21.7807 crs	-54.24%
EPS	₹7.77	₹16.97	-54.21%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 221.6817 crores during the period ended June 30, 2022 as compared to Rs.202.9426 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.9.9658 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.8.7345 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.7.77 for the period ended June 30, 2022 as compared to Rs.6.81 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 221.6817 crs	₹202.9426 crs	9.23%
Net Profit	₹9.9658 crs	₹8.7345 crs	14.10%
EPS	₹7.77	₹6.81	14.10%

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 1331.35 as compared to the previous close of Rs. 1345.05. The total number of shares traded during the day was 2341 in over 505 trades.

The stock hit an intraday high of Rs. 1367.50 and intraday low of 1320.00. The net turnover during the day was Rs. 3157047.00.

Source : Equity Bulls

Keywords

NeulandLaboratories Q1FY23 ResultUpdate